Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 43 Records) |
| Query Trace: Hypertension and CYP3A5[original query] |
|---|
| Association of the CYP3A5 polymorphism (6986G>A) with blood pressure and hypertension. Hypertension research : official journal of the Japanese Society of Hypertension 2011 Nov 34 (11): 1216-20. Xi Bo, Wang Chunyu, Liu Liu, Zeng Tao, Liang Yajun, Li Jun, Mi J |
| Association between CYP3A5 polymorphisms and blood pressure in kidney transplant recipients receiving calcineurin inhibitors. Clinical and experimental hypertension (New York, N.Y. : 1993) 2011 33 (6): 359-65. Ferraresso Mariano, Turolo Stefano, Ghio Luciana, Tirelli Amedea S, Belingheri Mirco, Villa Roberta, Groppali Elena, Edefonti Alber |
| Comparing antihypertensive effect and plasma ciclosporin concentration between amlodipine and valsartan regimens in hypertensive renal transplant patients receiving ciclosporin therapy. American journal of cardiovascular drugs : drugs, devices, and other interventions 2011 Dec 11 (6): 401-9. Cai Jingjing, Huang Zhijun, Yang Guoping, Cheng Ke, Ye Qifa, Ming Yingzi, Zuo Xiaocong, Zhou Peipei, Yuan Ho |
| Risk of tacrolimus toxicity in CYP3A5 nonexpressors treated with intravenous nicardipine after kidney transplantation. Transplantation 2012 Apr 93 (8): 806-12. Hooper David K, Fukuda Tsuyoshi, Gardiner Rhonda, Logan Barbara, Roy-Chaudhury Ashwini, Kirby Cassie L, Vinks Alexander A, Goebel Je |
| Effect of CYP3A51/3 polymorphism on blood pressure in renal transplant recipients. Transplantation proceedings 2012 Nov 44 (9): 2596-8. Torio A, Auyanet I, Montes-Ares O, Guerra R M, Fernandez E J, Perez M A, Ramirez A, Checa M |
Mining the unknown: a systems approach to metabolite identification combining genetic and metabolic information.
PLoS genetics 2012 8 (10): e1003005. Krumsiek Jan, Suhre Karsten, Evans Anne M, Mitchell Matthew W, Mohney Robert P, Milburn Michael V, Wägele Brigitte, Römisch-Margl Werner, Illig Thomas, Adamski Jerzy, Gieger Christian, Theis Fabian J, Kastenmüller Ga |
| Design of Allele Specific PCR for Rapid Detection of CYP3A5 (A6986G) and Mdr-1 (C3435T) Polymorphisms. Indian journal of clinical biochemistry : IJCB 2011 Jan 26 (1): 18-21. Ashavaid Tester F, Raje Himanshu S, Shah Bharat V, Shah Swarup |
| Association between urinary 6ß-hydroxycortisol/cortisol ratio and CYP3A5 genotypes in a normotensive population. Experimental and therapeutic medicine 2013 Feb 5 (2): 527-532. Rais Naushad, Hussain Arif, Chawla Yogesh Kumar, Kohli Krishan |
| Interaction between ALOX5AP and CYP3A5 gene variants significantly increases the risk for cerebral infarctions in Chinese. Neuroreport 2014 May 25 (7): 452-7. Chi Li-Fen, Yi Xing-Yang, Shao Min-Jie, Lin Jing, Zhou Qia |
| Hypertension-susceptibility gene prevalence in the Pacific Islands and associations with hypertension in Melanesia. Journal of human genetics 2013 Mar 58 (3): 142-9. Furusawa Takuro, Naka Izumi, Yamauchi Taro, Natsuhara Kazumi, Eddie Ricky, Kimura Ryosuke, Nakazawa Minato, Ishida Takafumi, Inaoka Tsukasa, Matsumura Yasuhiro, Ataka Yuji, Ohtsuka Ryutaro, Ohashi J |
| ABCB1 polymorphism and gender affect the pharmacokinetics of amlodipine in Chinese patients with essential hypertension: a population analysis. Drug metabolism and pharmacokinetics 2014 29 (4): 305-11. Zuo Xiao-cong, Zhang Wen-li, Yuan Hong, Barrett Jeffrey S, Hua Ye, Huang Zhi-jun, Zhou Hong-hao, Pei Qi, Guo Cheng-xian, Wang Jiang-lin, Yang Guo-pi |
| Effects of genetic factors on the pharmacokinetics and pharmacodynamics of amlodipine in primary hypertensive patients. Biomedical reports 2015 Mar 3 (2): 195-200. Guo Chengxian, Pei Q I, Tan Hongyi, Huang Zhijun, Yuan Hong, Yang Guopi |
| Benefits of minimizing immunosuppressive dosage according to cytochrome P450 3A5 genotype in liver transplant patients: findings from a single-center study. Genetics and molecular research : GMR 2015 14 (2): 3191-9. Wang L, Li N, Wang M X, Lu S |
| CYP2C8 rs17110453 and EPHX2 rs751141 two-locus interaction increases susceptibility to ischemic stroke. Gene 2015 Jul 565 (1): 85-9. Yi Xingyang, Zhang Biao, Wang Chun, Liao Duanxiu, Lin Jing, Chi Lif |
| Clinical effects of single nucleotide polymorphisms on drug-related genes in Japanese metastatic renal cell carcinoma patients treated with sunitinib. Anti-cancer drugs 2016 Aug . Numakura Kazuyuki, Tsuchiya Norihiko, Kagaya Hideaki, Takahashi Makoto, Tsuruta Hiroshi, Inoue Takamitsu, Narita Shintaro, Huang Mingguo, Satoh Shigeru, Niioka Takenori, Miura Masatomo, Habuchi Tomono |
| CYP3A5 as a candidate gene for hypertension: no support from an unselected indigenous West African population. Journal of human hypertension 2016 Dec 30 (12): 778-782. Fisher D L, Plange-Rhule J, Moreton M, Eastwood J B, Kerry S M, Micah F, Johnston A, Cappuccio F P, MacPhee I A |
| CYP3A4*1G and CYP3A5*3 genetic polymorphisms alter the antihypertensive efficacy of amlodipine in patients with hypertension following renal transplantation?. International journal of clinical pharmacology and therapeutics 2016 Nov . Huang Yun, Wen Gaiyan, Lu Yao, Wen Jia, Ji Ying, Xing Xiaowei, Li Ying, Wen Juan, Yuan Ho |
| Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell Carcinoma. European urology focus 2016 Dec 2 (6): 633-639. de Velasco Guillermo, Gray Kathryn P, Hamieh Lana, Urun Yuksel, Carol Hallie A, Fay Andre P, Signoretti Sabina, Kwiatkowski David J, McDermott David F, Freedman Matthew, Pomerantz Mark M, Choueiri Toni |
| Association between CYP3A5 genotypes with hypertension in Chinese Han population: A case-control study. Clinical and experimental hypertension (New York, N.Y. : 1993) 2017 39 (3): 235-240. Li Zhanzhan, Chen Peng, Zhou Tao, Chen Xiaofang, Chen Lizha |
| Interaction among CYP2C8, GPIIIa and P2Y12 variants increase susceptibility to ischemic stroke in Chinese population. Oncotarget 2017 Sep 8 (41): 70811-70820. Yi Xingyang, Lin Jing, Wang Yanfen, Zhou Ju, Zhou Qia |
| A new donors' CYP3A5 and recipients' CYP3A4 cluster predicting tacrolimus disposition, and new-onset hypertension in Chinese liver transplant patients. Oncotarget 2017 Sep 8 (41): 70250-70261. Liu Yuan, Zhang Tao, Zhang Xiaoqing, Ye Ling, Gu Haitao, Zhong Lin, Sun Hongcheng, Song Chenlong, Peng Zhihai, Fan Junw |
| Influence of CYP3A4/5 and ABC transporter polymorphisms on lenvatinib plasma trough concentrations in Japanese patients with thyroid cancer. Scientific reports 2019 Apr 9 (1): 5404. Ozeki Tomoko, Nagahama Mitsuji, Fujita Kazuma, Suzuki Akifumi, Sugino Kiminori, Ito Koichi, Miura Masato |
| Incorporation of Gene-Environment Interaction Terms Improved the Predictive Accuracy of Tacrolimus Stable Dose Algorithms in Chinese Adult Renal Transplant Recipients. Journal of clinical pharmacology 2019 Mar . Tang Jie, Xu Jing, Zhang Yue-Li, Liu Rong, Liu Mou-Ze, Hu Yong-Fang, Shao Ming-Jie, Zhu Li-Jun, Cao Shan, Xin Hua-Wen, Feng Gui-Wen, Shang Wen-Jun, Meng Xiang-Guang, Zhang Li-Rong, Ming Ying-Zi, Zhang Wei, Zhou G |
| Influence of Genetic Admixture Components on CYP3A5*3 Allele-Associated Hypertension in Amerindian Populations From Northwest Mexico. Frontiers in pharmacology 2020 6 11 638. Galaviz-Hernández Carlos, Lazalde-Ramos Blanca P, Lares-Assef Ismael, Macías-Salas Alejo, Ortega-Chavez Margarita A, Rangel-Villalobos Héctor, Sosa-Macías Mart |
| Influence of CYP2D6 and CYP3A5 Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Bisoprolol in Hypertensive Chinese Patients. Frontiers in medicine 2021 9 8 683498. Chan Sze Wa, Chu Tanya T W, Ho Chung Shun, Kong Alice P S, Tomlinson Brian, Zeng Weiw |
| CYP3A5 Genotype-Dependent Drug-Drug Interaction Between Tacrolimus and Nifedipine in Chinese Renal Transplant Patients. Frontiers in pharmacology 2021 7 12 692922. Yang Yilei, Huang Xin, Shi Yinping, Yang Rui, Shi Haiyan, Yang Xinmei, Hao Guoxiang, Zheng Yi, Wang Jianning, Su Lequn, Li Yan, Zhao W |
| Association of CYP3A5 Gene Polymorphisms and Amlodipine-Induced Peripheral Edema in Chinese Han Patients with Essential Hypertension. Pharmacogenomics and personalized medicine 2021 14 189-197. Liang Hao, Zhang Xinru, Ma Zhuo, Sun Yan, Shu Chang, Zhu Yihua, Zhang Yanwei, Hu Songnian, Fu Xiujuan, Liu Liho |
| Genetic Polymorphisms in CYP2C19 Cause Changes in Plasma Levels and Adverse Reactions to Anlotinib in Chinese Patients With Lung Cancer. Frontiers in pharmacology 2022 13 918219. Tan Tingfei, Han Gongwei, Cheng Ziwei, Jiang Jiemei, Zhang Li, Xia Zitong, Wang Xinmeng, Xia Qu |
| Pilot Study on the Impact of Polymorphisms Linked to Multi-Kinase Inhibitor Metabolism on Lenvatinib Side Effects in Patients with Advanced Thyroid Cancer. International journal of molecular sciences 2023 3 24 (6): . Cantara Silvia, Dalmiglio Cristina, Marzocchi Carlotta, Sagnella Alfonso, Brilli Lucia, Trimarchi Andrea, Maino Fabio, Valerio Laura, Castagna Maria Graz |
| Genetic and phenotypic frequency distribution of ACE, ADRB1, AGTR1, CYP2C9*3, CYP2D6*10, CYP3A5*3, NPPA and factors associated with hypertension in Chinese Han hypertensive patients. Medicine 2023 3 102 (10): e33206. Wang Zhenyun, Hou Juanjuan, Zheng Hongjun, Wang Dan, Tian Weihua, Zhang Dan, Yan Jiam |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 25, 2023
- Content source: